TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/24 18:26 | 6/7/24 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stein Jeffrey | CA | DO | P,CEO | P | 106 | 13.21 | 0 | 8 | 10 | 85 | I | ||||||||||||||
8/8/23 18:04 | 8/8/23 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stein Jeffrey | CA | DO | P,CEO | P | 48 | 0.9577 | 0 | 50 | 3 | 1,580 | I | ||||||||||||||
3/27/23 19:03 | 3/27/23 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stein Jeffrey | CA | DO | P,CEO | P | 52 | 1.04 | 0 | 50 | 4 | 1,246 | I | ||||||||||||||
2/23/23 14:27 | 2/21/23 | PRTK | Paratek Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stein Jeffrey | MA | D | S | -13 | 1.90 | 0 | -7 | -9 | 69 | D | |||||||||||||||
1/7/22 20:24 | 12/29/21 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stein Jeffrey | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 20 | 3 | 763 | D | ||||||||||||||
11/15/21 18:41 | 11/12/21 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stein Jeffrey | CA | DO | P,CEO | P | 80 | 1.59 | 0 | 50 | 7 | 739 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |